MENU
+Compare
WINT
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$0.22
Change
-$0.01 (-4.35%)
Capitalization
1.97M

WINT Windtree Therapeutics Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceuticals

Industry Biotechnology
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for WINT with price predictions
Jan 08, 2025

WINT in -14.06% downward trend, falling for three consecutive days on January 08, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where WINT declined for three days, in of 348 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for WINT entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for WINT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where WINT advanced for three days, in of 201 cases, the price rose further within the following month. The odds of a continued upward trend are .

WINT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.447) is normal, around the industry mean (14.744). P/E Ratio (0.826) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). WINT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.079).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. WINT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WINT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

WINT is expected to report earnings to fall 19.11% to -1050 cents per share on May 17

Windtree Therapeutics WINT Stock Earnings Reports
Q1'23
Est.
$-10.50
Q4'22
Missed
by $2.48
Q3'22
Beat
by $0.13
Q2'22
Missed
by $0.41
Q1'22
Beat
by $0.01
The last earnings report on March 30 showed earnings per share of -1297 cents, missing the estimate of -1050 cents. With 1.55M shares outstanding, the current market capitalization sits at 1.97M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2600 Kelly Road
Phone
+1 215 488-9300
Employees
20
Web
https://www.windtreetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRI5.850.03
+0.52%
Stoneridge
WSC36.640.07
+0.19%
WillScot Holdings Corporation
ONCT0.53N/A
N/A
Oncternal Therapeutics
CBAT0.89-0.01
-1.57%
CBAK Energy Technology
PD18.30-0.36
-1.93%
PagerDuty

WINT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been loosely correlated with MLEC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WINT jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
-3.44%
MLEC - WINT
49%
Loosely correlated
-1.29%
DVHGF - WINT
37%
Loosely correlated
N/A
INMB - WINT
31%
Poorly correlated
-4.02%
DYN - WINT
28%
Poorly correlated
-4.33%
ESLA - WINT
28%
Poorly correlated
+0.68%
More